Stay updated on Botensilimab and Balstilimab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Botensilimab and Balstilimab in Colorectal Cancer Clinical Trial page.

Latest updates to the Botensilimab and Balstilimab in Colorectal Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded a government funding notice and operating status details plus a version upgrade to v3.2.0; removed the v3.1.0 tag.SummaryDifference12%

- Check28 days agoChange DetectedVersion label updated from v3.0.2 to v3.1.0; core content and other critical data likely unchanged.SummaryDifference0.3%

- Check43 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing the previous Revision: v3.0.1, and the Back to Top element has been removed.SummaryDifference0.7%

- Check50 days agoChange DetectedThe web page has updated its revision number from v3.0.0 to v3.0.1 and has added a new date, 2025-09-04, while removing an older date, 2025-05-14.SummaryDifference2%

- Check57 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as multiple study status updates and eligibility criteria. However, several location-related terms have been removed.SummaryDifference16%

- Check71 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%

Stay in the know with updates to Botensilimab and Balstilimab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab and Balstilimab in Colorectal Cancer Clinical Trial page.